Orodispersible Tablets Market
完整報告名稱與涵蓋範圍
Orodispersible Tablets Market Size, Share & Trends Analysis Report by Drug Class (Analgesics, Antiemetics, Antipsychotics, Anti-inflammatory Drugs, Sedatives/Hypnotics, Antihypertensives, Others), By Disease Indication (Central Nervous System Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, Respiratory Disorders, Allergy and Asthma, Others), By Distribution Channel, By Age Group, By End User, By Technology , Region And Segment Forecasts, 2023-2031
報告摘要
A CAGR of 10.8% is forecasted for the global Orodispersible Tablets Market over the assessment period of 2025 through 2034.
Orodispersible Tablets covers The orodispersible tablets market, known as orally disintegrating tablets (ODTs), has acquired substantial interest and appeal in the pharmaceutical sector. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
The market's upward path is driven by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region set to deliver the strongest growth trajectory through the forecast period, driven by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Orodispersible Tablets Market Snapshot
Chapter 4. Global Orodispersible Tablets Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: By Drug Class Estimates & Trend Analysis
5.1. By Drug Class & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Drug Class:
5.2.1. Analgesics
5.2.2. Antiemetics
5.2.3. Antipsychotics
5.2.4. Anti-inflammatory Drugs
5.2.5. Sedatives/Hypnotics
5.2.6. Antihypertensives
5.2.7. Others
Chapter 6. Market Segmentation 2: By Disease Indication Estimates & Trend Analysis
6.1. By Drug Class & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Disease Indication:
6.2.1. Central Nervous System Disorders
6.2.2. Gastrointestinal Disorders
6.2.3. Cardiovascular Disorders
6.2.4. Respiratory Disorders
6.2.5. Allergy and Asthma
6.2.6. Others
Chapter 7. Market Segmentation 3: By Distribution Channel Estimates & Trend Analysis
7.1. By Drug Class & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Distribution Channel:
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online Pharmacies
Chapter 8. Market Segmentation 4: By Age Group Estimates & Trend Analysis
8.1. By Drug Class & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Age Group:
8.2.1. Pediatric Patients
8.2.2. Adult Patients
8.2.3. Geriatric Patients
Chapter 9. Market Segmentation 5: By End-User Estimates & Trend Analysis
9.1. By Drug Class & Market Share, 2024-2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-User :
9.2.1. Hospitals
9.2.2. Clinics
9.2.3. Ambulatory Surgical Centers
9.2.4. Homecare Settings
Chapter 10. Market Segmentation 6: By Technology Range Estimates & Trend Analysis
10.1. By Age Group & Market Share, 2024-2034
10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Technology Range:
10.2.1. Lyophilization
10.2.2. Tablet Molding
10.2.3. Spray Drying
10.2.4. Sublimation
10.2.5. Others
Chapter 11. Orodispersible Tablets Market Segmentation 10: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Drug Class, 2021-2034
11.1.2. North America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
11.1.3. North America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Distribution Channel , 2021-2034
11.1.4. North America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Age Group, 2021-2034
11.1.5. North America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By End-User , 2021-2034
11.1.6. North America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Technology Range, 2021-2034
11.1.7. North America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
11.1.7.1. U.S.
11.1.7.2. Canada
11.2. Europe
11.2.1. Europe Orodispersible Tablets Market revenue (US$ Million) by By Drug Class, 2021-2034
11.2.2. Europe Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
11.2.3. Europe Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Distribution Channel , 2021-2034
11.2.4. Europe Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Age Group, 2021-2034
11.2.5. Europe Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By End-User , 2021-2034
11.2.6. Europe Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Technology Range, 2021-2034
11.2.7. Europe Orodispersible Tablets Market revenue (US$ Million) by country, 2021-2034
11.2.7.1. Germany
11.2.7.2. Poland
11.2.7.3. France
11.2.7.4. Italy
11.2.7.5. Spain
11.2.7.6. UK
11.2.7.7. Rest of Europe
11.3. Asia Pacific
11.3.1. Asia Pacific Orodispersible Tablets Market revenue (US$ Million) by By Drug Class, 2021-2034
11.3.2. Asia Pacific Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Age Group, 2021-2034
11.3.3. Asia Pacific Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
11.3.4. Asia Pacific Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Distribution Channel , 2021-2034
11.3.5. Asia Pacific Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Age Group, 2021-2034
11.3.6. Asia Pacific Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By End-User , 2021-2034
11.3.7. Asia Pacific Orodispersible Tablets Market revenue (US$ Million) by country, 2021-2034
11.3.7.1. China
11.3.7.2. India
11.3.7.3. Japan
11.3.7.4. Australia
11.3.7.5. Rest of Asia Pacific
11.4. Latin America
11.4.1. Latin America Orodispersible Tablets Market revenue (US$ Million) by By Drug Class, 2021-2034
11.4.2. Latin America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Age Group, 2021-2034
11.4.3. Latin America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
11.4.4. Latin America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Distribution Channel , 2021-2034
11.4.5. Latin America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Age Group, 2021-2034
11.4.6. Latin America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By End-User , 2021-2034
11.4.7. Latin America Orodispersible Tablets Market revenue (US$ Million) by country, (US$ Million) 2021-2034
11.4.7.1. Brazil
11.4.7.2. Rest of Latin America
11.5. Middle East & Africa
11.5.1. Middle East & Africa Orodispersible Tablets Market revenue (US$ Million) by By Drug Class, (US$ Million)
11.5.2. Middle East & Africa Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Age Group, 2021-2034
11.5.3. Middle East & Africa Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
11.5.4. Middle East & Africa Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Distribution Channel , 2021-2034
11.5.5. Middle East & Africa Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Age Group, 2021-2034
11.5.6. Middle East & Africa Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By End-User , 2021-2034
11.5.7. Middle East & Africa Orodispersible Tablets Market revenue (US$ Million) by country, (US$ Million) 2021-2034
11.5.7.1. South Africa
11.5.7.2. GCC Countries
11.5.7.3. Rest of MEA
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. AstraZeneca PLC,
12.2.2. GlaxoSmithKline PLC,
12.2.3. Novartis International AG,
12.2.4. Johnson & Johnson Services, Inc.,
12.2.5. Teva Pharmaceutical Industries Ltd.,
12.2.6. Merck & Co., Inc.,
12.2.7. Pfizer Inc.,
12.2.8. Cipla Limited,
12.2.9. Dr. Reddy's Laboratories Ltd.,
12.2.10. Sun Pharmaceutical Industries Ltd.,
12.2.11. Lupin Pharmaceuticals, Inc.,
12.2.12. Torrent Pharmaceuticals Ltd.,
12.2.13. F. Hoffmann-La Roche Ltd.,
12.2.14. Eisai Co., Ltd.,
12.2.15. Takeda Pharmaceutical Company Limited.
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們